ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 80 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $527,000 | +160.9% | 113,437 | +85.3% | 0.00% | +50.0% |
| Q4 2020 | $202,000 | -2.4% | 61,218 | -2.3% | 0.00% | -33.3% |
| Q3 2020 | $207,000 | -57.6% | 62,645 | -56.7% | 0.00% | -62.5% |
| Q2 2020 | $488,000 | +369.2% | 144,760 | +739.0% | 0.01% | +700.0% |
| Q4 2019 | $104,000 | +15.6% | 17,254 | +44.9% | 0.00% | 0.0% |
| Q3 2019 | $90,000 | -32.3% | 11,909 | -51.3% | 0.00% | 0.0% |
| Q1 2019 | $133,000 | +9.9% | 24,453 | +64.5% | 0.00% | 0.0% |
| Q3 2018 | $121,000 | -9.7% | 14,861 | +8.1% | 0.00% | -50.0% |
| Q2 2018 | $134,000 | -46.0% | 13,742 | -30.7% | 0.00% | -50.0% |
| Q4 2017 | $248,000 | – | 19,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |